Characteristics of Opioid Toxicity Deaths Among Adolescents and Young Adults in Ontario Prior To and During the COVID-19 Pandemic
Crown Copyright © 2024. Published by Elsevier Inc. All rights reserved..
PURPOSE: To characterize opioid toxicity deaths among adolescents and young adults in Ontario, Canada, prior to and during the first year of the COVID-19 pandemic.
METHODS: We conducted a descriptive, cross-sectional study of opioid toxicity deaths among individuals aged 15-24 in Ontario in the year prior to (March 17, 2019, to March 16, 2020) and the first year of the pandemic (March 17, 2020, to March 16, 2021) using administrative health databases. We analyzed circumstances surrounding death, substances contributing to death, and health-care encounters prior to death.
RESULTS: We identified 284 deaths among Ontarians aged 15-24, including 115 in the year preceding and 169 in the first year of the pandemic. Fentanyl contributed to 84.3% of deaths in the prepandemic year, rising to 93.5% (p = .012) the following year. Stimulants contributed to approximately half of deaths in both periods (41.7% prepandemic and 49.1% during pandemic). In both periods, roughly one in 4 decedents had a health-care encounter in the week prior to death and less than 20% of those with an opioid use disorder received opioid agonist treatment in the 30 days prior to death.
DISCUSSION: Among young Ontarians, the number of opioid-related deaths increased by 47% in the first year of the COVID-19 pandemic. Fentanyl contributed to the vast majority of deaths, with non-opioid substances (primarily stimulants) also contributing to approximately half of deaths. Patterns of health-care utilization prior to death suggest opportunities to better connect this population to services that address opioid use disorder needs and promote harm reduction.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
The Journal of adolescent health : official publication of the Society for Adolescent Medicine - (2024) vom: 09. Apr. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Akbar, Sadia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 10.04.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.jadohealth.2024.02.024 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370871782 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370871782 | ||
| 003 | DE-627 | ||
| 005 | 20240410233633.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240410s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jadohealth.2024.02.024 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1371.xml |
| 035 | |a (DE-627)NLM370871782 | ||
| 035 | |a (NLM)38597841 | ||
| 035 | |a (PII)S1054-139X(24)00114-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Akbar, Sadia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Characteristics of Opioid Toxicity Deaths Among Adolescents and Young Adults in Ontario Prior To and During the COVID-19 Pandemic |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 10.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Crown Copyright © 2024. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a PURPOSE: To characterize opioid toxicity deaths among adolescents and young adults in Ontario, Canada, prior to and during the first year of the COVID-19 pandemic | ||
| 520 | |a METHODS: We conducted a descriptive, cross-sectional study of opioid toxicity deaths among individuals aged 15-24 in Ontario in the year prior to (March 17, 2019, to March 16, 2020) and the first year of the pandemic (March 17, 2020, to March 16, 2021) using administrative health databases. We analyzed circumstances surrounding death, substances contributing to death, and health-care encounters prior to death | ||
| 520 | |a RESULTS: We identified 284 deaths among Ontarians aged 15-24, including 115 in the year preceding and 169 in the first year of the pandemic. Fentanyl contributed to 84.3% of deaths in the prepandemic year, rising to 93.5% (p = .012) the following year. Stimulants contributed to approximately half of deaths in both periods (41.7% prepandemic and 49.1% during pandemic). In both periods, roughly one in 4 decedents had a health-care encounter in the week prior to death and less than 20% of those with an opioid use disorder received opioid agonist treatment in the 30 days prior to death | ||
| 520 | |a DISCUSSION: Among young Ontarians, the number of opioid-related deaths increased by 47% in the first year of the COVID-19 pandemic. Fentanyl contributed to the vast majority of deaths, with non-opioid substances (primarily stimulants) also contributing to approximately half of deaths. Patterns of health-care utilization prior to death suggest opportunities to better connect this population to services that address opioid use disorder needs and promote harm reduction | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Adolescents | |
| 650 | 4 | |a Opioid | |
| 650 | 4 | |a Opioid use disorder | |
| 650 | 4 | |a Toxicity | |
| 700 | 1 | |a Iacono, Anita |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Joanna |e verfasserin |4 aut | |
| 700 | 1 | |a Antoniou, Tony |e verfasserin |4 aut | |
| 700 | 1 | |a Juurlink, David |e verfasserin |4 aut | |
| 700 | 1 | |a Sheikh, Hasan |e verfasserin |4 aut | |
| 700 | 1 | |a Kurdyak, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Fangyun |e verfasserin |4 aut | |
| 700 | 1 | |a Cheng, Clare |e verfasserin |4 aut | |
| 700 | 1 | |a Leece, Pamela |e verfasserin |4 aut | |
| 700 | 1 | |a Kolla, Gillian |e verfasserin |4 aut | |
| 700 | 1 | |a Emblem, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Shearer, Dana |e verfasserin |4 aut | |
| 700 | 1 | |a Gomes, Tara |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of adolescent health : official publication of the Society for Adolescent Medicine |d 1996 |g (2024) vom: 09. Apr. |w (DE-627)NLM012715484 |x 1879-1972 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:09 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jadohealth.2024.02.024 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 09 |c 04 | ||